Anuraj Phunyal

Anuraj Phunyal

Auto-generated profile, based on publicly available information

Anuraj Phunyal

Affiliation Central Department of Chemistry, Tribhuvan University, Kirtipur, Kathmandu, Nepal

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
APAnuraj Phunyal
Anuraj Phunyal
AAAchyut Adhikari
Achyut Adhikari
Jhashanath Adhikari SubinJhashanath Adhikari Subin
Jhashanath Adhikari Subin
Dengue poses a persistent and widespread threat with no effective antiviral drug available till now. Several inhibitors have been developed by targeting the viral non-structural proteins including methyl transferase (NS5) of the dengue virus with possible therapeutic values. In this work, virtual screening, molecular docking, molecular dynamics simulations (200 ns), and assessments of free energy changes have been carried out to identify potential candidates from a database of flavonoids (ca. 2000) that may have good curative potential from the disease. The binding affinity of flavonoids, namely Genistein-7-glucoside (FLD1), 6’–O-Acetylgenistin (FLD2), 5,6-dihydroxy-2-(4-hydroxyphenyl)-7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxane-2-yl]oxychromen-4-one (FLD3), Glucoliquiritigenin (FLD4), and Chrysin-7-O-glucoronide (FLD5) showed the binding affinities of −10.2, −10.2, −10.1, −10.1, −9.9 kcal/mol, respectively, and possessed better values than that of the native ligand (−7.6 kcal/mol) and diclofenac sodium (−7.3 kcal/mol). Drug-likeness of the top five flavonoids were acceptable and no end-point toxicity was hinted by ADMET predictions. The stability of the protein-ligand complexes was accessed from 200 ns molecular dynamics simulations in terms of various geometrical parameters; RMSD, RMSF of residues, Rg, SASA, H-bond, and RPDF. The binding free energy changes of these adducts were calculated by the MM/PBSA solvation model with negative values (from −38.01±7.53 to −17.75±11.03 kcal/mol) indicating the sustained spontaneity of the forward reaction and favorability of the product formation. The geometrical and thermodynamic parameters inferred that the flavonoids could bind at the orthosteric site of the target protein of DENV-2 and could inhibit its functioning, possibly, resulting in the prevention of the disease. Overall, this study highlights the anti-DENV activity of five flavonoids, positioning them as promising candidates for further development as antiviral agents against dengue infection.

9 July 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AWAmar Waiba
Amar Waiba
APAnuraj Phunyal
Anuraj Phunyal
TLTika Ram Lamichhane
Tika Ram Lamichhane
Madhav GhimireMadhav Ghimire
Madhav Ghimire
HNHari Nyaupane
Hari Nyaupane
AAAchyut Adhikari
Achyut Adhikari
Dengue virus is a critical worldwide health concern, and efforts to identify useful antiviral drugs remain imperative. This study utilized computational techniques to investigate the flavonoids as a potential inhibitor of the dengue virus envelope protein (PDB ID: 1OKE). 33 flavonoids were docked among them, 5-hydroxy-3-(4-hydroxyphenyl)-7-[(2S, 3R, 4S, 5S, 6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one (FLA1) showed the best binding affinity of ˗9.1 kcal/mol towards the E protein. Molecular dynamics simulations (100 ns) were carried out to analyze the stability and interaction of protein-ligand complexes, including parameters such as RMSD (FLA1 of 2.36 ± 0.43 Å), RMSF, Rg, SASA, hydrogen bonding, and RDF. In addition, PCA and DCCM analysis exposed considerable conformational differences and residue correlations favoring FLA1 stability. The binding free energy calculations using the MM/PBSA methodology confirmed the strong binding (˗29.1 ± 5.83 kcal/mol) of FLA1 to the target protein. ADMET profiling also revealed good pharmacokinetic properties. These findings suggest FLA1 is a possible inhibitor of the dengue virus and a promising drug candidate for the development of antiviral drugs in the future.

28 March 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
APAnuraj Phunyal
Anuraj Phunyal
Jhashanath Adhikari SubinJhashanath Adhikari Subin
Jhashanath Adhikari Subin
AAAchyut Adhikari
Achyut Adhikari
Dengue poses a persistent and widespread threat with no effective antiviral drug available till now. Several inhibitors have been developed by targeting the viral non-structural proteins including methyl transferase (NS5) of the dengue virus with possible therapeutic values. In this work, virtual screening, molecular docking, molecular dynamics simulations (200 ns), and assessments of free energy changes to identify potential candidates from a database of flavonoids (ca. 2000) that may have good curative potential from the disease. The binding affinity of flavonoids, namely Genistein-7-glucoside (FLD1), 6’–O-Acetylgenistin (FLD2), 5,6-dihydroxy-2-(4-hydroxyphenyl)-7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxane-2-yl]oxychromen-4-one (FLD3), Glucoliquiritigenin (FLD4), and Chrysin-7-O-glucoronide (FLD5) showed the binding affinities of −10.2, −10.2, −10.1, −10.1, −9.9 kcal/mol, respectively, and possessed better values than that of the native ligand with showed (−7.6 kcal/mol) and diclofenac sodium (−7.3 kcal/mol). Drug-likeness of these compounds was acceptable and no toxicity was hinted by ADMET predictions. The stability of the protein-ligand complexes was accessed from 200 ns molecular dynamics simulation in terms of various geometrical parameters; RMSD, RMSF of residues, Rg, SASA, and H-bond of the protein-ligand complexes. The binding free energy changes of these compounds were calculated by the MM-PBSA solvation model with negative values (less than −38.01±7.53 kcal/mol) indicating the spontaneity of the forward reaction and favorability of the product formation. The geometrical and thermodynamic parameters infer that the flavonoid binds at the orthosteric site of the target protein of DENV-2 and could inhibit its functioning resulting in the prevention of the disease. Overall, this study highlights the anti-DENV activity of five flavonoids, positioning them as promising candidates for further development as antiviral agents against dengue infection.

1 July 2026 in Journal of Institute of Science and Technology
Verified
Journal Article
Open access
NMNitesh Mallik
Nitesh Mallik
APAshish Phuyal
Ashish Phuyal
APAnuraj Phuyal
Anuraj Phuyal
NBNarendra Bhatta
Narendra Bhatta
AWAmar Waiba
Amar Waiba
AAAchyut Adhikari
Achyut Adhikari
Cancer remains a major global health challenge, and existing drugs have limited efficacy and adverse side effects. Key molecular regulators such as PARP1, ABL1, and CDK2 represent attractive targets for developing safer and more effective anticancer agents. MDA468 (Breast cancer), HCT-116 (Colon Cancer), CCRF (Leukemia), MDA-MB-435 (Melanoma), HOP-18 (non-small lung cancer), SKOV3 (Ovarian cancer), DU-145(Prostate cancer), and SN12K1 (Renal cancer) are cell lines studied in this paper. 216 phytoecdysteroids were computationally screened against these targets using molecular docking, ADMET profiling, and molecular dynamics simulations (MDS). Among them, Ecdysterone 22-benzoate 25-O-β-D-glycoside (PES 1) exhibited strong binding affinities of –11.3 kcal/mol (3L3M) and –9.1 kcal/mol (8H7H), while E-2-Deoxy-20-hydroxyecdysone 3-[4-(1-β-D-glucopyranosyl)]-caffeate (PES 44) demonstrated affinities of –9.3 kcal/mol (2A0C) and –9.2 kcal/mol (8H7H). Both complexes maintained RMSD values below 2 Å, and ADMET predictions further indicated favourable pharmacokinetic properties and low predicted toxicity. These findings suggest that PES 1 and PES 44 are promising phytoecdysteroid-based inhibitors with potential anticancer activity, warranting further extended simulations and experimental validation for their development into effective and safer anticancer therapeutics.